---
schema_version: "secwatch.filing_event.v1"
accession: "0001809519-24-000048"
form_type: "8-K"
ticker: "GDRX"
cik: "0001809519"
company_name: "GoodRx Holdings, Inc."
filed_at: "2024-03-14T23:59:59+00:00"
generated_at: "2026-06-04T21:28:58.694652+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# GoodRx interim CEO Scott Wagner extends commitment; two board directors resign

## Summary
- Scott Wagner's employment agreement revised to indefinite term, annual cash bonus target 100% of base salary.
- Wagner granted $8M in equity ($4M options, $4M RSUs) vesting monthly over eight months starting May 8, 2024.
- Stephen LeSieur resigns from board effective March 14, 2024; Adam Karol resigns effective March 22, 2024.
- Both directors cited no disagreement; LeSieur departure follows repurchase of Spectrum shares from him.

## SEC filing metadata
- accession: 0001809519-24-000048
- form_type: 8-K
- ticker: GDRX
- cik: 0001809519
- company_name: GoodRx Holdings, Inc.
- filed_at: 2024-03-14T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1809519/000180951924000048/0001809519-24-000048-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1809519/000180951924000048/gdrx-8xkxitem502x701x901in.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001809519-24-000048
- JSON: https://secwatch.observer/filing/0001809519-24-000048.json
- Plain text: https://secwatch.observer/filing/0001809519-24-000048.txt

## Key facts
- Executive change
  Adam Karol resigned as Director at GoodRx Holdings, Inc..
  - Action: resigned
  - Role: Director
  source text: On March 12, 2024, Adam Karol notified the Company of his decision to resign as a member of the Board, effective as of March 22, 2024, including from his service on the Board’s Compliance Committee and Nominating and Corporate Governance Committee.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1809519/000180951924000048/0001809519-24-000048-index.htm
- Executive change
  Stephen LeSieur resigned as Director at GoodRx Holdings, Inc..
  - Action: resigned
  - Role: Director
  source text: Also on March 12, 2024, Stephen LeSieur notified the Company of his decision to resign as a member of the Board, effective as of March 14, 2024, including from his service on the Board’s Compliance Committee.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1809519/000180951924000048/0001809519-24-000048-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.